A Clinical Study of CAR-T Treating Relapsed or Refractory T Cell Lymphoblastic Acute Leukemia/ Lymphoma
Guangzhou Bio-gene Technology Co., Ltd
Guangzhou Bio-gene Technology Co., Ltd
Gyala Therapeutics
Beijing GoBroad Hospital
Eastern Cooperative Oncology Group
M.D. Anderson Cancer Center
Beijing GoBroad Hospital
Beijing GoBroad Hospital
Otsuka Medical Devices Co., Ltd. Japan
Abramson Cancer Center at Penn Medicine
Princess Maxima Center for Pediatric Oncology
Princess Maxima Center for Pediatric Oncology
Princess Maxima Center for Pediatric Oncology
Princess Maxima Center for Pediatric Oncology
M.D. Anderson Cancer Center
Bristol-Myers Squibb
Peking University People's Hospital
Essen Biotech
Princess Maxima Center for Pediatric Oncology
Beijing Tongren Hospital
Cellestia Biotech AG
Children's Oncology Group
Atara Biotherapeutics
Memorial Sloan Kettering Cancer Center
Therapeutic Advances in Childhood Leukemia Consortium
Mayo Clinic
Therapeutic Advances in Childhood Leukemia Consortium
Mayo Clinic
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Eli Lilly and Company
Sichuan University
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
National Cancer Institute (NCI)
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Asan Medical Center
Mundipharma Research Limited
Northwestern University
UNC Lineberger Comprehensive Cancer Center
NYU Langone Health
Fred Hutchinson Cancer Center